(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ARENSIA EXPLORATORY MEDICINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ARENSIA EXPLORATORY MEDICINE

ST13

US500000079431113

Class

42

Filing

79431113

Registration

8209026

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

07/14/2026

Trademark type

Combined

Nice classes

42

Filing date

06/04/2025

Registration date

04/14/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/14/2026

Last transaction

07/14/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

DE

Examiner

ARRISON, RACHEL MARIE

Law office

L60

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "ARENSIA EXPLORATORY MEDICINE", where "ARENSIA" is in red above the wording "EXPLORATORY MEDICINE", which is in black. To the left of the wording is a design of black figure, formed by a filled-in circle and a curved vertical line on either side, with four red horizontal curved lines around its middle.

Holders and representatives

Holders

ARENSIA Exploratory Medicine GmbH

Representatives

Kristina Montanaro Schrader Adams & Reese, LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific research in the nature of conducting clinical trials for others; clinical and medical researchproviding scientific research in the field of clinical trialsconducting clinical research in the field of respiratory scienceconducting pharmaceutical clinical trials for others; scientific research services for others in the fields of cardiologyimmunologymetabolic disordersrespiratoryendocrinologygastro-enterologyhepatologynephrologydermatologyurologyoncologypsychiatryneurologyhematologyinfectious diseasesophthalmologygynaecology; scientific reportsproviding scientific information in the fields of cardiologyimmunologymetabolic disordersrespiratoryendocrinologygastro-enterologyhepatologynephrologydermatologyurologyoncologypsychiatryneurologyhematologyinfectious diseasesophthalmologygynaecology; research on the subject of pharmaceuticals; scientific research consultancy; scientific consultancy servicesscientific research consultancy in the fields of cardiologyimmunologymetabolic disordersrespiratoryendocrinologygastro-enterologyhepatologynephrologydermatologyurologyoncologypsychiatryneurologyhematologyinfectious diseasesophthalmologygynaecology

Publications

History of USPTO decisions and trademark events.

19 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

07/14/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/14/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/14/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/24/2026

PUBO

PUBLISHED FOR OPPOSITION

02/24/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/18/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/30/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/29/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/29/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/29/2026

RFNT

REFUSAL PROCESSED BY IB

01/01/2026

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

12/12/2025

RFRR

REFUSAL PROCESSED BY MPU

12/12/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/05/2025

CNRT

NON-FINAL ACTION WRITTEN

11/04/2025

DOCK

ASSIGNED TO EXAMINER

10/23/2025

MAFR

APPLICATION FILING RECEIPT MAILED

08/29/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/29/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/28/2025

Continuous trademark protection

Get notified about every new filing that threatens ARENSIA EXPLORATORY MEDICINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.